In a groundbreaking study published recently, researchers have begun to unravel the transformative potential of genomics-guided off-label treatments in cancer...

The US Food and Drug Administration (FDA) is currently reassessing the approval of Roche’s flagship drug, ocrelizumab (marketed as Ocrevus),...

In a groundbreaking development that could redefine therapeutic strategies against prostate cancer, researchers have uncovered the intricate molecular mechanism by...

A groundbreaking study from Memorial Sloan Kettering Cancer Center (MSK) has unveiled intricate mechanisms by which pancreatic cells harboring oncogenic...

In a groundbreaking study published in the latest issue of Oncotarget, researchers have unveiled critical insights into the epigenetic mechanisms...

The landscape of gastric cancer research has taken a compelling turn with the recent unveiling of secreted SULF1 protein's pivotal...

In a groundbreaking study published in Nature, researchers have unveiled the early cellular dynamics that underlie the emergence of malignancy...

In a groundbreaking advancement poised to reshape cancer care in South Texas, UT Health San Antonio Multispecialty and Research Hospital...

In a groundbreaking collaborative effort, researchers from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have unearthed...

In a transformative leap for biotechnology, Houston-based RBL LLC has unveiled Duracyte, a groundbreaking biotech firm poised to revolutionize the...